ABSTRACT: A predominant justification for health psy-
Progressive versions of the medical model acknowlchology and behavioral medicine is that behavior or enedge that the cause of illness might be environmental or vironmental conditions affect a biological process. Thus, the lesion psychosocial. Even the biopsych0social model many investigators focus attention on the effects of be- (Engle, 1976) , however, concentrates on sickness and its havior on cell pathology and blood chemistry. This article causes. Attention is directed toward the psychological or argues that behavioral outcomes arethe most important environmental etiology and the physiological lesion consequences in studies of health care and medicine. These (White, 1988 
whatever method produces the most health benefit
In this context the definition of behavior is general, as at the lowest cost.
offered by Atkinson, Atkinson, Smith, and Hilgard (1987) in their widely used introductory psychology textbook. They define behavior as "those activities of an organism Health psychology and behavioral medicine are among that can be observed by another organism or by an exthe most rapidly developing areas of psychological reperimenter's instruments" (p, 657) . Includedin behavior search and practice. Although no one model has domiare verbal reports about subjective conscious experiences. Hated the field, the biomedical disease model has guided
In this article, I refer to biological measures as measures most thinking. According to this model, syndromes exof physiological state. Biological measures and disease pressed as signs and symptoms are associated with lesions classifications are important precisely because they are or some underlying pathology. This pathology is the focus predictors or mediators of behavioral outcomes. of research and the target of treatment. Interventions are
In the following sections, I argue that there has been made to eradicate the lesion or prevent its pathogenesis, too much concentration on purely biological measures The lesion, however, is the central focus of examination, and that the importance of behavioral health outcomes Reviews of the emerging field of behavioral medicine has been undervalued.
and health psychology often emphasize the role of beBehavioral Health Outcomes havior in the onset, maintenance, and treatment of disease (Miller, 1983) . Many of these reviews characterize the The conceptualization and measurement of health status role of stress on bodily processes. Krantz, Grunberg, and has interested scholars for many decades. After the EiBaum (1985) emphasized the links between behavior and senhower administration, a report of the President's health through basic physiological mechanisms. Their
Commission on National Goals, (1960) identified health review concluded with an emphasis on new technologies status measurement as an important objective. In his infor assessing physiologic, rather than behavioral, health fluential book, The Affluent Society, John Kenneth Galoutcomes. For example, they pointed to the availability braith (1958) described the need to measure the effect of of portable blood-withdrawal pumps, blood pressure the health care system on quality of life. In recent years monitors, and biochemical assessment tools. Rodin and there have been many attempts to define and measure Salovey (1989) underscored the importance of disease end health status. points: They encouraged health psychologists to focus on
The movement toward behavioral measures is an placement in specific disease categories such as cancer or old one. When Sullivan (1966) reviewed the literature on coronary heart disease. These reviews characterize the health measurement nearly a quarter of a century ago, field as emphasizing the impact of behavior on identified he emphasized the importance of behavioral outcomes. lesions or specific disease states.
Bolstered by the accomplishments of behavioral scientists, Sullivan developed a convincing argument that behavioral as well as current health status. Cancer, for example, may indicators such as absenteeism, bed-disability days, and have very little impact on current functioning but may institutional confinement were the most important conhave a substantial impact on behavioral outcomes in the sequences of disease and disability. Ability to' perform future. Today, a person with a malignant tumor in a leg act'wities at different ages could be compared with societal may be functioning very much like a person with a leg standards for these behaviors. Restrictions in usual activity muscle injury. However, the cancer patient is more likely were seen as prima facie evidence of deviation from wellto remain dysfunctional in the future. Comprehensive being. Health conditions affect behavior, and in this article expressions of health status need to incorporate estimates behavioral health outcomes are conceptualized as obof future behavioral dysfunction as well as to measure servable behavioral consequences of a health state. Arcurrent status (Kaplan & Anderson, 1988) . thritis, for example, may be associated with difficulty in
The spectrum of medical care ranges from public walking, observable limping, or problems in using the health, preventive medicine, and environmental control hands. Even a minor illness, such as the common cold_ through diagnosis to therapeutic intervention, convalesmight result in disruptions in daily activities, alterations cence, and rehabilitation. Many programs affect the in activity patterns, and decreased work capacity, probability of occurrence of future dysfunction rather Diseases and disabilities are important for two reathan alter present functional status. In many aspects of sons. First, illness may cause a truncation of the life expreventive care, for example, the benefit of the treatment pectancy. In other words, those in specific disease carecannot be seen until many years after the intervention. gories may die prematurely. Death is a behavioral out-A supportive family that instills proper health habits in come. It can be defined as the point at which there is no its children, for example, may also promote better health observable behavior. Second, diseases and disabilities may in the future, even though the benefit may not be realized cause behavioral dysfunctions as well as other symptoms, for years. The concept of health must consider not only Biomedical studies typically refer to health outcomes in the ability to function now but also the. probability of terms of mortality (death) and morbidity (dysfunction) future changes in function or probabilities of death. A and sometimes to symptoms, person who is functional and asymptomatic today may Mortality remains the major outcome measure in harbor a disease with a poor prognosis. Thus, many inmost epidemiologic studies and clinical trials. In order dividuals are at high risk of dying from heart disease even to make informed decisions about the nation's health, though they are perfectly functional today. Should we call Congress receives various reports of statistical indicators them healthy? The term severity of illness should take from the National Center for Health Statistics. These ininto consideration both dysfunction and prognosis. clude the crude mortality rate, the infant mortality rate, Comprehensive models that combine morbidity, mortaland years of potential life lost. Although important, each ity, and prognosis have been described in the literature of these measures ignores dysfunction while people are (Kaplan & Anderson, 1988) . A behavioral conceptualalive. The National Center for Health Statistics provides ization of health status can represent this prognosis by information on a variety of states of morbidity. For exmodeling disruptions in behavior that might occur in the ample, it considers disability, defined as a temporary or future. long-term reduction in a person's activity. Over the last Many medical treatments may cause near-term dys-15 years, medical and health services researchers have function to prevent future dysfunction. For example, developed new ways to assess health status quantitatively, coronary artery bypass surgery causes severe dysfunction These measures are often called qualit_ of life measures, for a short period of time, yet the surgery is presumed to Because they are used exclusively to evaluate health status, enhance function or decrease mortality at a later time. the more descriptive health-related quality of life is prePatients may be incapacitated following myocardial inferred (Kaplan & Bush, 1982) . Some approaches to the farction and restricted to coronary care units. Yet the measurement of health-related quality of life combine treatment is designed to help them achieve better future measures of morbidity and mortality to express health outcomes. Pap smears and hysterectomies are performed outcomes in units analogous to years of life. The yearsin order to decrease the probability of future deaths due of-life figure, however, is adjusted for diminished quality to cancer. Much of health care involves looking into the of life associated with diseases or disabilities (Kaplan & future to enhance behavioral outcomes over the life span. Anderson, 1988) .
Therefore, it is essentialto divide health into current and Modern measures of health outcome consider future future components.
In appraising the importance of behavioral outAn earlier version of this article was prepared for the American Psycomes, we must ask why there is concern about diseases, chologicalAssociation,Division 38 Symposium, NewOrleans, Louisiana, injuries, and disabilities. The behavioral perspective sugAugust 1989.
geststhat the only reasonsare the following: (a) LifeexCritical commentsby Mark B. Andersenand Catherine J. Atkins, pectancy may be shortened, (b) quality of life may be w. A_Hillix, Melbourne Hovell,and Thomas L. Patterson on an earlier compromised either now or at some time prior to death, version of this article are sincerely appreciated.
or (c) some combination of a and b. A disease that has Correspondence concerning this article should be addressed to Robert M. Kaplan, Divisionof Health Care Sciences,M-022, School of no impact on either life expectancy or life quality would Medicine, University of California, SanDiego,La Jolla,CA92093-0622. be unimportant.
In fact, disease states gain their impor-tance precisely to the degree to which they correlate with screening test provides essentially no information relevant decreased longevity or impaired health-related quality of to health outcome. Elevated blood cholesterol may be life.
predictive of future bad outcomes, including early morThe importance of behavioral outcomes has not been tality from heart disease. However, other lipids in blood disregarded by the traditional medical community. In fact, such as very low-density lipoproteins or chylomicrons may recognition of the centrality of behavioral outcomes has bear little relation to health outcomes in all but the most been emphasized in several articles and editorials recently extreme cases. Modest elevation in these fractions of blood featured in The New England Journal of Medicine (Elllipids may be of little concern. wood, 1988; Greenfield, 1989; Shortell & McNerney, Recently there has been a significant growth of in-1990). Despite the growing recognition of the importance terest in the relation between stress and measurable asof behavioral outcomes by the medical community (Adpects of immune function. Temoshok, Soloman, and vances in Health Status Assessment, 1987; Bergner, 1989;  Jenkins ( Immunologists are uncertain about whether absolute manifest a paradoxical reluctance to follow this trend, numbers or percentages of cell subtypes are most meanInstead, the trend has been to focus on measures ofbioingful. Most important, the immune system is a genuine logical process, system in which various components adjust to changes in one another, and some important aspects of the system
Trend Toward Biological Variables as may remain to be identified. Our understanding of the Opposed to Behavioral Indexes relation between immune parameters and health is still very sketchy. We are witnessing a trend toward the biologicalization of Biological measures are also assumed to be more both behavioral and biomedical sciences. Reviews of the reliable than behavioral tests. Often however, the relihealth psychology literature criticize studies that do not ability of these measures is not assessed. When data are focus on some aspect of blood chemistry or those that do available, the results can be discouraging. Many investinot use disease categories (Baum, Grunberg, & Singer, gators, fascinated by blood pressure as an outcome meal 982). Measures of biological process are seen to be more sure, have criticized behavioral measures for being nonpure, more reliable, and more valid than are behavioral physiologic and unreliable. Yet the reliability of blood indicators. Thus, an increasing number of studies assess
pressure is equally open to question because conventional health status through measures of blood cholesterol, blood sphygmomanometric measurements have poor test-retest pressure, or characteristics of the immune response, incoefficients. This leads to misclassification, incorrect dieluding natural killer-cell and t-cell activity. W. T. Kelvin agnosis, and potentially damaging labeling (Hla, Vokaty, created the doctrine that measurement is the prerequisite & Fuessner, 1986; Patterson, 1984) . There are many to science. For most of this century, scientists and clinisources of error in blood pressure measurement. These cians followed the doctrine and attempted to use meainclude misreading biases, time sampling problems (blood sures, even when the validity of the measures was unpressure changes minute to minute), and situational facknown. Feinstein (1967) suggested that modern trends tors. For example, it has been demonstrated that some represent the "curse of Kelvin." The fact that there is a patients have specific arousal of blood pressure in the measure for some variable does not always mean that the presence of physicians. The condition has now been given measure is useful. ClinicianS have been more attracted the diagnostic label white coat hypertension (Pickering et to blood pressure and cardiac output than to headache al., 1988). Low reliability is not limited to blood pressure. and anxiety. Clearly, the former are easier to quantify, It also characterizes measures of blood cholesterol, glubut are they more meaningful?
cose, and a large number of other biochemical assays. It is important to emphasize that not all biological One of the important appeals of biological measures variables are measures of health status or health outcome, is that they focus on objectively defined events. Behavioral They are, however, predictive of some health outcomes, outcomes are often not measured objectively. Observer Elevated blood pressure, for example, is important bebias common to behavioral measures may be less corncause it predicts premature mortality or behavioral dysmon with biological measures. However, at a conceptual function resulting from coronary heart disease and from level, behavioral outcomes can represent defined events stroke. If blood pressure were unrelated to these behavsuch as exercise or role performance. Subjective events, ioral outcomes, it would be a matter of little concern, such as pain or discomfort, are characterized in pain beThere are many aspects of blood chemistry that bear no haviors and through verbal behaviors. It is tempting to relation to clinical outcomes. Even common clinical tests, assume that biological measures are more valid and resuch as urine analysis, serum phosphorus, and alkaline liable because they have less observer bias. However, they phosphatase, have only weak and inconsistent relations may include several other sources of measurement error to outcomes in all but the most extreme cases. Amberg, and they do not necessarily have evidence for validity. Schneiderman, Berry, and Zettner (1982) , for example, To summarize, in order to avoid known problems demonstrated empirically that the alkaline phosphatase with behavioral measures, researchers and clinicians have been attracted to outcomes that can be measured with sure (DBP) exceeding 90 mmHg. Using these guidelines, biochemical assays, mechanical devices, or auto-analyzer it has been estimated that as many 58 million adults machines. Although these measures are not subject to (about 30% of the adult population) have hypertension the same errors as behavioral tests, they have their own (Joint National Committee on Detection, Evaluation, and sources of error and often have low reliability and quesTreatment of High Blood Pressure, 1985 1984). In addition, evidence from the HDFP (1979) has It is often assumed that the relation between the biologic demonstrated that reductions in blood pressure result in variables and health outcomes is nearly perfect. However, reductions in deaths due to heart disease. People are often there is a remarkable variability in behavioral health outnot concerned about high blood pressure because it may comes within fixed levels of many biological variables, produce no symptoms or current behavioral dysfunction. There are numerous examples, of which only three will High blood pressure does have a bad prognosis, with afbe considered: biologic measures of arthritis, blood presfected individuals being at risk for behavioral dysfunction sure, and blood cholesterol. The arthritis example emor death later in life. However, the relation between blood phasizes current behavioral health outcomes, whereas the pressure and both mortality and morbidity are far from latter two focus on future behavioral outcomes and moruniform. Severe elevated blood pressure is a severe risk tality, for mortality, whereas blood pressure in the mild hypertension range (DBP = 90-104 mmHg) is a less significant Arthritis risk (Rocella, Bowler, & Horan, 1987) . Indeed, most of Clinical outcomes in studies of rheumatology have been those with mild hypertension, even those untreated, have difficult to evaluate (Deyo, 1988) . Clinical measures often normal life expectancies with no complications. include joint tenderness, grip strength, and joint circumAlthough high blood pressure is associated with ference. Some studies have shown that the reliability of risks, the treatment of high blood pressure may cause these measures is often poor (Buchanan, 1982) . Fries some problems. Significant numbers of patients experi-(1983) questioned the validity and reliability of a variety ence dizziness, tiredness, and impotence when treated of traditional outcome measures, ranging from laboratory with medications (Breckenridge, 1988) . Thus, the treatmeasures of erythrocyte sedimentation rate (ESR), latex ment of high blood pressure can cause undesirable health fixation titer, and hemoglobin. It has been shown that outcomes. Treatment, like hypertension, is a factor that rheumatoid arthritis patients may develop serological abmay influence behavioral health outcomes, sometimes in normalities that are poorly correlated with joint inflamthe negative direction. Studies that measure only blood mation (McCarty, 1986) . In addition, Fries suggested that pressure and neglect these behavioral side effects will traditional clinical measures such as grip strength, walking overestimate the net benefit. Conversely, too much focus time, and patient global assessment are merely surrogates on side effects might lead to an incorrect judgment that for the true outcomes in arthritis, which he argued are the treatment should be avoided. There may be considdisability, physical discomfort, and financial loss. An elerable advantage in translating the side effects and benefits evated ESR means little to a patient who feels fine and into common behavioral units and weighing them against can conduct his or her life without pain. The ESR charone another in the treatment decision process (Kaplan & acterizes current inflammation but does not give infor- Atkins, 1989) . The role of the clinician is to balance caremation about future dysfunction. Conversely, a patient fully the benefits and consequences of treatment (Aderwith disabling arthritis pain is not well when the ESR is man & Madhavan, 1981). normal. Clinical tests are useful only when they identify In summary, blood pressure is an important risk treatment to remedy current dysfunction or predict future factor for heart disease and stroke. Systematic efforts to problems. Fries asserted that pain and functional outreduce blood pressure are advisable and effective. Yet, comes are meaningful to the patients and that clinical blood pressure is not a health outcome. It gains its immeasures are of less importance. As a result, a growing portance through validity studies that demonstrate the number of rheumatologists are focusing attention on beassociation between blood pressure and behavioral outhavioral or functional health outcomes (Anderson, Fircomes including mortality, dysfunction, and symptomatic schein, & Meenan, 1989 Group (1988 Group ( , 1989 ), physician subjects were asconsidered to be diagnostic (Expert Panel on Detection, signed to take aspirin (325 mg/day) or placebo in order Evaluation, and Treatment of High Blood Cholesterol in to prevent myocardial infarctions. The ultimate aim, of Adults, 1988) . Several epidemiologic studies have idencourse, was to reduce the number of deaths associated tiffed elevated blood cholesterol as a risk factor for carwith heart disease. Indeed, there was a significant reducdiovascular disease mortality (Kannel, Castelli, Gordon, tion in deaths from myocardial infarctions over an eight-& McNamara, 1971 ). Yet the connection between dietary year follow-up period. This result was highly publicized cholesterol and serum cholesterol has been less clearly and even earned aspirin the description of a "miracle established. Studies in metabolic wards and selected exdrug" on the cover of Newsweek magazine (Clark, Gosperimental studies do demonstrate that dietary manipnell, Hager, Carroll, & Gordon, 1988 ). Yet closer inspeculation can reduce serum cholesterol in the short run, tion of the data reveals that there was no advantage of although longer term changes have not been clearly docaspirin for the crucial behavioral outcome--life or death. umented. Furthermore, although there have been ecoThe top panel of Figure 1 shows deaths from all cardiological correlations between estimated total fat consumpvascular categories in the Physician's Health Study. This tion and total heart disease mortality across cultures, corstacking histogram reveals that reductions in death from relations within countries have not been systematically myocardial infarction were compensated for by increases observed (Kaplan, 1985) . A variety of explanations can in death from other cardiovascular causes. There was a be suggested for these "nonfindings." For example, meatrend toward more hemorrhagic strokes among those surement error in both dietary cholesterol and serum taking aspirin, and there was the suggestion that aspirin cholesterol may account for the null results (Jacobs, Anmay cause these strokes because it reduces blood clotting. derson, & Blackburn, 1979) . But the availability of an Overall, aspirin did not reduce the number of deaths but explanation for a nonfinding is not a demonstration that changed the distribution among categories (Kaplan, a significant association exists . Thus, the 1989b). relation between dietary cholesterol and serum cholesterol
The center portion of Figure 1 shows a similar result is somewhat ambiguous, for the Coronary Primary Prevention Trial (Lipid ReStallones (1983) criticized the diet-heart-disease search Clinics Coronary Prevention Trial Results, 1984). connection, suggesting that there is no zero-order relation
In this study, a group of about 1,900 men at risk for between diet and mortality. The problems with the chocoronary heart disease was given cholestyramine, a resin lesterol interventions have been reviewed in several earlier that binds bial acids and lowers serum cholesterol, whereas articles (Fries, Green, & Levine, 1989; Kaplan, 1984, another group of about 1,900 men was given a placebo. 1985). These positions are regarded as controversial, but Among the 3,800 male participants, 38 (2%) in the control they are related to the current issue, group and 30 (1.6%) in the experimental group died of The reason that cholesterol is important is that elheart disease. The study is widely cited as the crucial evated cholesterol is a risk factor for behavioral health evidence for cholesterol reduction. In addition, data from outcomes. If it were not, why would one care? The imthe study have been used to argue that a 1% reduction in portant point is that the outcome itself must be considcholesterol results in a 2% reduction in mortality. This ered. The role of the investigator is to determine the rehas come to be known in health promotion campaigns lation between modifiable habits (dietary patterns) and as the 1% to 2% rule. The exact calculation of this 1% to outcomes as mediated through the channel of serum cho-2% rule, so often cited in public statements, is difficult lesterol. Serum cholesterol can serve as a target for modto follow. Forming a ratio of these small percentages of ification, but one must be assured that modifying serum deaths and subtracting from 1.0 gives the estimate of cholesterol improves outcome and does not adversely afabout a 21% reduction in mortality (1. Specific Causes for the current campaign toward cholesterol reduction. Some investigators, recognizing the problems with meaThe stacking histogram does suggest a significant reducsures of disease process, turn their attention toward the tion in heart disease deaths among those randomly asultimate medical outcome--death.
AS noted earlier in signed to cholestyramine. Yet the entire height of the this review, vital status is considered to be a behavioral bars in the stacking histogram shows that there was no outcome. However, the behavioral approach differs from advantage of treatment for total mortality. According to the traditional medical model in its emphasis on lifethe behavioral conceptualization, the treatment had no death status without reference to medical cause of death, benefit. Reductions in death from heart disease were The emphasis is on observable outcome rather than on compensated for by increases in death from other causes. diseasecategory.
The lowerportion of Figure 1 showssimilar results Many medical studies confuse outcome with placefrom the Helsinki Heart Study, which evaluated a similar ment in disease categories. Results from several recent drug called gemfibrozil (Frick et al., 1987) . In the Helsinki _H r_ fl ....i i _ _l i fibrozil caused a 26% reduction in ischemic heart disease Figure 1 deaths. The 26% is calculated as follows: •-ical model that would explain why decreased cholesterol ® ,01 should lead to increased deaths in nondisease categories. a However, the finding that cholesterol lowering does not reduce total mortality has now been reported in several 20 different studies (Fries et at., 1989 ,, portant life-death outcome (see total height of columns in each section of Figure 1 ). Investigators and the lay press often focus on improvements in a specific cause of death. Yet families of the deceased may be more concerned that the subject is dead than they are about the Cho,e_n_ P,_bo specific cause of demise. Focus on specific categories can Group obscure the most important behavioral outcomes. Research directed toward specific disease categories or asHelsinki Heart Study pects of a biological process may not capture global concerns about health. That task requires a comprehensive Accidenvviolence Other _, behavioral model. pathology, which makes up most of the study of medicine ""'"'"'"'" I;_',';,';",';';';'" and results in most of the serious illnesses. These illnesses ",',',',',','," might be caused by multiple sources, including inherited o .:':':',:':',,':', _, ',',',',',',',.,.,.,.,.,., ., birth problems, various diseases, the aging process, defects Gemfibtozil Placebo in the genetic program, and accidents. Each of these Group problems may be caused by biochemical or structural
Note. CVD = cardiovascular disease; sudden = sudden death; MI = myocardial problems. The sources listed in Figure 2 are selected exinfarction; CHD= coronary heart disease, amples and are not intended to be exhaustive. Investigators are concerned about these biological problems because they may eventually affect behavior. If a disease or condition had an impact on a tissue or organ system but study, 2,051 men were randomly assigned to take gemhad no effect on life expectancy, no effect on function, fibrozil twice daily, whereas another 2,030 men were given no effect on appearance or symptoms, would it be of cone placebo. After six years, 19 of the men in the placebo cern? group had died of ischemic heart disease, whereas only Most models in health psychology and behavioral 14 of those in the drug-treated group had died. This sigmedicine have a biological measure on the right side (imnificant difference led the authors to conclude that gemplying that biology is the outcome). It is often emphasized that behavior is important because it can affect biological some investigators have reported that coffee increases low process. For example, diet can affect serum cholesterol density lippoprotein cholesterol or blood pressure (Thelle, and stress can affect natural killer cells. Figure 2 suggests Heyden, & Fodor, 1987) . Because cholesterol and blood a different focus. Both biological and environmental pressure are risk factors for heart disease, people are adevents gain their importance because they affect behavior, vised to give up the coffee they enjoy. The logic behind this advice might be challenged, however, as coffee does Can a Behavioral Conceptualization Influence not increase the risk of heart disease or other behavioral Research and Practice? health outcomes. Focus on biological rather than behavioral outcomes has Treatment of factors suspected of causing undesirled many investigators down the wrong path. For example, able behavioral outcomes is usually advisable. Yet change elevated levels of protein in urine suggest that the kidneys in these risk factors does not assure that the behavioral are misfiltering and removing some proteins that the body goal will be achieved. One recent example is the treatment needs. Many years ago, when physicians measured high of cardiac arrhythmias. Research had demonstrated that levels of protein in urine, they advised their patients to adults who had suffered a heart attack were at risk for eat less protein. That advice led to poorer health outcomes sudden death if they experienced asymptomatic cardiac because the body was already protein deprived. Ultiarrhythmias (Bigger, Fleiss, Kleiger, Miller, & Rolnitzky, mately, identifying the manipulations that led to better 1984). Drugs were available to suppress these cardiac arbehavioral health outcomes led to more effective treatrhythmias, and these products were used often. In what ments. Another example involves the diagnosis and many thought was a demonstration of the obvious, the treatment of back pain. Legal definitions of disability National Institutes of Health initiated a major clinical sometimes require a physical diagnosis, and the medical study involving 1,455 post myocardial infarction patients evaluation often identifies a structural problem. This leads in a variety of major medical centers (Cardiac Arrhythmia to the incorrect conclusion that the prognosis is poor.
Suppression Trial [CAST] Investigators, 1989). The paThus, the medical model reinforces dysfunction, even tients were randomly assigned to take anti-arrhythmic though rehabilitation is common. A comprehensive view medication or placebos. All of the participants had been of health can reveal when new treatment approaches are screened and demonstrated to experience suppression of needed, whereas focus on specific processes might mistheir arrhythmia in response to the medication. Over an direct treatment, average of 10 months of follow-up, however, those assigned The traditional approach leads to a focus on risk to the active drug had a significantly higher rate of death factors rather than on health outcomes. Yet, modification from arrhythmia than those assigned to the placebo. In of risk factors may not necessarily improve health. For addition, those in the active medication group had a example, many epidemiologic studies have failed to find higher overall death rate. If the investigators had only a relation between coffee consumption and death due to measured the response of the heart rhythm to anti-atheart disease. Several very thorough evaluations have rhythmic drugs, they would have concluded that the drug shown that those who drink coffee have the same life produced a benefit. Following the patients through the expectancies as those who abstain (Wilson, Garrison, behavioral outcome (mortality) inspired them to stop the Kannel, McGee, & Costelli, 1989) . On the other hand, trial early and declare the medications unsafe.
The important point is that physiologic and bioto these problems. On the other hand, several disabilities chemical measures do not necessarily have meaning. They do not respond to medicines or surgeries. For these, begain their meaning through systematic correlations with havioral interventions may be thebest alternative for prohealth outcome. Attention directed at behavioral health ducing a health benefit. Using behavioral outcomes as outcomes can clarify the importance of biological prothe target of care allows different alternatives to compete. cesses.
Ultimately, treatments should be favored if they produce the most benefit at the lowest cost.
Pathways to Health Outcomes
In this article I have argued that the only important outSummary comes in health and illness are behavioral. Clearly, these
Physicians have long recognized that disease categories outcomes are deserving of one's attention. People expend provide minimal information about the impact of illness tremendous resources in order to achieve better health upon patient experiences (Ellwood, 1988) . A diagnosis is status. In fact, in the United States, more is spent on important because it may identify a course of treatment. health care than on food (Kaplan, 1989a) . How might Yet within specific diagnoses, patients differ considerably one realize the best return on one's investments in terms in how they are affected. Multiple sclerosis, for example, of health outcomes?
may have essentially no impact on behavioral dysfunction There are at least two ways to achieve better health or it could have devastating implications. The impact of outcomes. The first is through the modification of methe disease on the daily life of the patient may be more diators of the behavioral outcomes. This is accomplished important than naming the condition. A recent editorial by identifying tissue pathology and seeking its remedy, in the Journal of the American Medical Association conThus, those with diabetes experience poor health outcluded that physicians need to learn to "treat the patient, comes because of a problem in insulin production or not the disease" (Riesenberg & Glass, 1989, p. 943) . insulin action. By supplying more insulin or by tuning There are only two health outcomes that are of imup insulin receptors, better health outcomes may be portance. First, there is life expectancy. Second, there is achieved. Those with tumors may experience better health function or quality of life during the years that people outcomes with the tumors excised. There is nothing wrong are alive. Biological and physical events are mediators of with the medical model. In fact, direct treatment of pathese behavioral outcomes. Individuals are concerned thology (lesions) remains one of the best methods for imabout Cancer, high blood pressure, high cholesterol, or proving health outcomes. The traditional practice of other problems because they may shorten the life expecmedicine and surgery should be viewed as a set of methods tancy or make life less desirable prior to death. There is designed to improve behavioral outcomes, a growing consensus that these behavioral outcomes are Another pathway for improving health outcomes incentral in studies of health care and medicine. Yet revolves modification of behavior, independent of the disfinement of these measures requires active participation ease pathway. For example, patients with chronic obof behavioral scientists. Although behavioral outcomes structive pulmonary disease may face a situation in which are gaining a stronger foothold in medical research, psythere are no known medical or surgical remedies. Howchologists and behavioral scientists have shown minimal ever, behavior modification programs may enhance funcinterest. A behavioral conceptualization of health outtioning independent of improvement in disease state (Atcomes may suggest important new directions for research kins, Kaplan, Reinsch, Lofback, & Timms, 1984; Kaplan and practice. & Atkins, 1988) . Pain treatment may also benefit from this conceptualization. Substantial evidence now suggests REFERENCES that pain and suffering are distinct. Pain behavior can continue after the injury that initiated the pain has healed. . (1982) . measurable ways (Fordyce, 1988) . Health outcomes are
The "abnormal" outpatient chemistry panel serum alkaline phosbehavioral, and one way to improve them is to modify phatase: Analysis of physicianresponse, outcome, cost and health effectiveness. (1982) . The use ofpsychocan be surgically repaired and it would be inappropriate logicaland neuroendocrinologicalmeasurements in the studyof stress. to use behavioral treatment to modify outcomes related HealthPsychology, 1, 217-236.
